Sotera Health (SHC) Cash from Investing Activities (2020 - 2026)
Sotera Health (SHC) posted quarterly Cash from Investing Activities of -$45.1 million for Q1 2026, down 126.99% year-over-year from $167.2 million in Q1 2025, and up 10.99% on a QoQ basis from -$50.7 million in Q4 2025.
Sotera Health (SHC) Cash from Investing Activities (2020 - 2026) Analysis & Trends
Sotera Health (SHC) has reported Cash from Investing Activities for 7 consecutive years, with -$45.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 126.99% year-over-year to -$45.1 million; the TTM figure through Mar 2026 stood at -$160.4 million (up 2.21% YoY), while the FY2025 annual figure was -$135.1 million, up 24.5% from the prior year.
- Cash from Investing Activities came in at -$45.1 million for Q1 2026 at Sotera Health, up from -$50.7 million in the prior quarter.
- The five-year high for Cash from Investing Activities was -$19.9 million in Q1 2025, with the low at -$71.7 million in Q4 2022.
- Average Cash from Investing Activities over 5 years is -$44.5 million, with a median of -$41.9 million recorded in 2024.
- Across the five-year window, Cash from Investing Activities tumbled 134.79% in 2022 and soared 42.96% in 2025, its largest moves.
- Year by year, Cash from Investing Activities stood at -$71.7 million in 2022, then increased by 9.64% to -$64.8 million in 2023, then retreated by 1.61% to -$65.9 million in 2024, then climbed by 23.03% to -$50.7 million in 2025, then climbed by 10.99% to -$45.1 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$45.1 million, -$50.7 million, and -$33.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 95.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -8.96 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -249.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -33.54 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -32.14 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -77.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -196.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -366.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -31.35 Mn |
| 10 | Sotera Health | 5.06 Bn | 4.74 Bn | 147.07 Mn | -45.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.13 Mn |
| Mar 31, 2026 | -45.13 Mn |
| Dec 31, 2025 | -50.70 Mn |
| Dec 31, 2025 | -50.70 Mn |
| Sep 30, 2025 | -33.34 Mn |
| Sep 30, 2025 | -33.34 Mn |
| Jun 30, 2025 | -31.23 Mn |
| Jun 30, 2025 | -31.23 Mn |
| Mar 31, 2025 | -19.88 Mn |
| Mar 31, 2025 | -19.88 Mn |
| Dec 31, 2024 | -65.87 Mn |
| Dec 31, 2024 | -65.87 Mn |
| Sep 30, 2024 | -36.35 Mn |
| Sep 30, 2024 | -36.35 Mn |
| Jun 30, 2024 | -41.92 Mn |
| Jun 30, 2024 | -41.92 Mn |
| Mar 31, 2024 | -34.85 Mn |
| Mar 31, 2024 | -34.85 Mn |
| Dec 31, 2023 | -64.83 Mn |
| Dec 31, 2023 | -64.83 Mn |